LakeShore Biopharma Co., Ltd (LSBCF) — Financial Flexibility Index
LakeShore Biopharma Co., Ltd (LSBCF) has a Financial Flexibility Index of -0.01x as of June 2022. Free cash flow of $-693.96K (operating CF $-693.96K minus capex $0.00) represents 0% of total liabilities ($76.38 Million). Check LSBCF cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LakeShore Biopharma Co., Ltd Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for LakeShore Biopharma Co., Ltd across 5 annual periods. For the full cash flow conversion analysis, see LSBCF cash flow conversion.
Annual Financial Flexibility Index for LakeShore Biopharma Co., Ltd (2021–2025)
Year-by-year free cash flow to debt coverage for LakeShore Biopharma Co., Ltd. Explore how well can LakeShore Biopharma Co., Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-103.12 Million | $-120.98 Million | $867.91 Million | ▲ +56.1% |
| 2024 | -0.27x | $-250.98 Million | $-295.23 Million | $927.82 Million | ▼ -113.8% |
| 2023 | -0.13x | $-125.42 Million | $-182.47 Million | $991.30 Million | ▼ -102.1% |
| 2022 | 6.16x | $125.39 Million | $-173.55 Million | $20.35 Million | ▲ +100.3% |
| 2021 | -2024.38x | $-141.73 Million | $-246.61 Million | $70.01K | — |